Lazari Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$9.82K	Hold	10,817	–	–	﹤0.01%	155
2025 Q1	$4.89K	Sell	10,817 -147	-1%	-$66	﹤0.01%	153
2024 Q4	$5.51K	Buy	+10,964	New	+$5.51K	﹤0.01%	152